✦ LIBER ✦

Pharmacological inhibition of PARP-1 reduces α-synuclein- and MPP+-induced cytotoxicity in Parkinson’s disease in vitro models

✍ Scribed by Tiago Fleming Outeiro; Tom N. Grammatopoulos; Steven Altmann; Allison Amore; David G. Standaert; Bradley T. Hyman; Aleksey G. Kazantsev

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Statins reduce neuronal α-synuclein aggr

✍ Pazit Bar-On; Leslie Crews; Andrew O. Koob; Hideya Mizuno; Anthony Adame; Brian 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 885 KB

Differential inhibition of α-synuclein o

✍ Ronit Shaltiel-Karyo; Dan Davidi; Moran Frenkel-Pinter; Michael Ovadia; Daniel S 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 789 KB

Parkinson’s disease-associated mutations

✍ Chiho Konya; Yusuke Hatanaka; Yuuki Fujiwara; Kenko Uchida; Yoshitaka Nagai; Kei 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 847 KB

Mutant α-synuclein and aging reduce neur

✍ Jun Peng; Julie K. Andersen 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 597 KB

dl-3-n-Butylphthalide prevents oxidative

✍ Jin-zhong Huang; Ying-zhu Chen; Min Su; Hui-fen Zheng; Ya-ping Yang; Jing Chen; 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 591 KB

Mitochondrial Inhibitor Models of Huntin

✍ Sheline, Christian T.; Zhu, Julia; Zhang, Wendy; Shi, Chunxiao; Cai, Ai-Li 📂 Article 📅 2012 🏛 S. Karger AG 🌐 English ⚖ 553 KB